Trademark: 90980842
Word
ADC THERAPEUTICS
Status Date
Tuesday, March 19, 2024
Filing Date
Thursday, November 5, 2020
Published for Opposition
Tuesday, May 24, 2022
5 Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for use in the treatment of cancer and tumors; pharmaceutical preparations for use in the treatment of oncological diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, pharmaceutical antibodies; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of oncological diseases, disorders, and conditions; pharmaceutical preparations for the treatment of oncological diseases, disorders, and conditions; biological preparations for the treatment of oncological diseases, and conditions
44 Providing medical information; providing information in the fields of healthcare, therapeutic properties of pharmaceuticals, and health
42 Pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals
The mark consists of the letters "ADC" above the word "THERAPEUTICS". A wave element extends across the letter "A" to a shared edge of the letters "D" and "C".
"THERAPEUTICS"
Mar 20, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 19, 2024
Allowed Principal Register - Sou Accepted
Feb 27, 2024
Notice Of Design Search Code E-Mailed
Feb 26, 2024
Statement Of Use Processing Complete
Jan 18, 2024
Use Amendment Filed
Feb 26, 2024
Divisional Processing Complete
Jan 18, 2024
Divisional Request Received
Feb 5, 2024
Case Assigned To Intent To Use Paralegal
Jan 18, 2024
Teas Request To Divide Received
Jan 18, 2024
Teas Statement Of Use Received
Jul 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 13, 2023
Sou Extension 2 Granted
Jul 13, 2023
Sou Extension 2 Filed
Jul 13, 2023
Sou Teas Extension Received
Jan 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 18, 2023
Sou Extension 1 Granted
Jan 18, 2023
Sou Extension 1 Filed
Jan 18, 2023
Sou Teas Extension Received
Jul 19, 2022
Noa E-Mailed - Sou Required From Applicant
May 24, 2022
Official Gazette Publication Confirmation E-Mailed
May 24, 2022
Published For Opposition
May 4, 2022
Notification Of Notice Of Publication E-Mailed
Apr 20, 2022
Exparte Appeal Terminated
Apr 20, 2022
Approved For Pub - Principal Register
Apr 13, 2022
Teas/Email Correspondence Entered
Apr 13, 2022
Correspondence Received In Law Office
Apr 12, 2022
Assigned To Lie
Apr 7, 2022
Assigned To Lie
Apr 6, 2022
Teas Request For Reconsideration Received
Apr 6, 2022
Ex Parte Appeal-Instituted
Apr 6, 2022
Jurisdiction Restored To Examining Attorney
Apr 6, 2022
Exparte Appeal Received At Ttab
Oct 6, 2021
Notification Of Final Refusal Emailed
Oct 6, 2021
Final Refusal E-Mailed
Oct 6, 2021
Final Refusal Written
Aug 6, 2021
Teas/Email Correspondence Entered
Aug 5, 2021
Correspondence Received In Law Office
Aug 5, 2021
Teas Response To Office Action Received
Feb 6, 2021
Notification Of Non-Final Action E-Mailed
Feb 6, 2021
Non-Final Action E-Mailed
Feb 6, 2021
Non-Final Action Written
Feb 2, 2021
Assigned To Examiner
Jan 7, 2021
Notice Of Design Search Code E-Mailed
Jan 6, 2021
New Application Office Supplied Data Entered
Nov 9, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
